Instil Bio Inc (TIL)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2025 | 12-2024 | 12-2023 | 12-2022 | 12-2021 | |
| Operating Expenses | 78,581 | 73,541 | 159,169 | 226,458 | 155,560 |
| Operating Income | -78,581 | -73,541 | -159,169 | -226,458 | -155,560 |
| Interest Expense | 5,829 | 8,992 | 5,209 | 1,883 | 0 |
| Other Income | 13,038 | 8,398 | 8,291 | 3,091 | -1,195 |
| Pre-tax Income | -71,372 | -74,135 | -156,087 | -225,250 | -156,755 |
| Income Tax | 0 | 0 | 0 | -2,073 | 39 |
| Net Income Continuous | -71,372 | -74,135 | -156,087 | -223,177 | -156,794 |
| Net Income | $-71,372 | $-74,135 | $-156,087 | $-223,177 | $-156,794 |
| EPS Basic Total Ops | -10.70 | -11.39 | -24.00 | -34.46 | -29.60 |
| EPS Basic Continuous Ops | -10.70 | -11.39 | -24.00 | -34.46 | -29.59 |
| EPS Diluted Total Ops | -10.70 | -11.39 | -24.00 | -34.46 | -29.60 |
| EPS Diluted Continuous Ops | -10.70 | -11.39 | -24.00 | -34.46 | -29.59 |
| EPS Diluted Before Non-Recurring Items | -10.70 | -11.39 | -24.00 | -34.40 | -29.60 |
| EBITDA(a) | $-78,047 | $-69,931 | $-154,413 | $-204,645 | $-152,808 |